Search

Displaying results 9701 - 9710 of 9710 in total
  1. Drug

    XM146-MPA-SN38

    go.drugbank.com/drugs/DB32865
    Experimental

    XM146-MPA-SN38 is a PDL1-targeting polypeptide-MPA-SN38 conjugate.

  2. Drug

    TN-301

    go.drugbank.com/drugs/DB32867
    Experimental

    TN-301 is a small-molecule histone deacetylase 6 inhibitor.

  3. Drug

    AZD-8965

    go.drugbank.com/drugs/DB32868
    Experimental

    AZD-8965 is a small molecule inhibitor of ARG-1 and ARG-2.

  4. Drug

    RGN6024

    go.drugbank.com/drugs/DB33059
    Experimental

    RGN6024, also known as RGN-6024 or RGNi6024, is a synthetic small-molecule tubulin destabilizer from Reglagene.

  5. Drug

    CRTKVA11-03

    go.drugbank.com/drugs/DB33965
    Experimental

    CRTKVA11-03 is a biologic drug. CRTKVA11-03 is under investigation in clinical trial NCT07826585 (Treatment of Patients With Advanced Solid Tumors Using CRTKVA11-03 TCR-T Cell Injection).

  6. Drug

    PRX-P4-003

    go.drugbank.com/drugs/DB33967
    Experimental

    PRX-P4-003 is a small molecule drug. … PRX-P4-003 is under investigation in clinical trial NCT04638803 (A Phase 0, Open-Label, Crossover Microdose Pharmacokinetic Study of PRX-P4-003 in Healthy Volunteers).

  7. Drug

    HEC-921

    go.drugbank.com/drugs/DB33971
    Experimental

    HEC-921 is a biologic drug.

  8. Drug

    RO7830698

    go.drugbank.com/drugs/DB33974
    Experimental

    RO7830698 is a biologic drug. RO7830698 is under investigation in clinical trial NCT07822334 (A Study of RO7830698 in Healthy Participants and Participants With Chronic Obstructive Pulmonary Disease).

  9. Drug

    177Lu-NI-FAPI

    go.drugbank.com/drugs/DB33977
    Experimental

    177Lu-NI-FAPI is a small molecule drug. 177Lu-NI-FAPI is under investigation in clinical trial NCT07822347 (Research on NI-FAPI-04 for the Treatment of Hypoxic and Fibroblast Activation Protein Related

  10. Drug

    ONO-4915

    go.drugbank.com/drugs/DB33978
    Experimental

    ONO-4915 is a small molecule drug. ONO-4915 is under investigation in clinical trial NCT07823790 (ONO-4915 in Patients With Primary Sjogren's Disease).